The Influence of Cardiovascular Disease on Health Related Quality of Life in Men With Prostate Cancer: A 4-Year Followup Study

Journal of Urology

Volumn 179, Issue 4, 2008, Pages 1362-1367

  van de Poll Franse, Lonneke V ^a,b   Kwan, Lorna ^b   Reiter, Robert E ^b   Lee, Steve P ^b   Litwin, Mark S ^b  

^a The Netherlands   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular diseases; comorbidity; prostatic neoplasms; quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SCORING SYSTEM; SEXUAL DYSFUNCTION;

ADENOCARCINOMA; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 40849118248     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.11.086     Document Type: Article

References (19)

1. Houterman S., Janssen-Heijnen M.L., Hendrikx A.J., van den Berg H.A., and Coebergh J.W. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol 58 (2006) 60
2. Hall H.I., Satariano W.A., Thompson T., Ragland K.E., Van Den Eeden S.K., and Selvin S. Initial treatment for prostate carcinoma in relation to comorbidity and symptoms. Cancer 95 (2002) 2308
3. van de Poll-Franse L.V., Houterman S., Janssen-Heijnen M.L., Dercksen M.W., Coebergh J.W., and Haak H.R. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120 (2007) 1986
4. Ramsey S.D., Zeliadt S.B., Hall I.J., Ekwueme D.U., and Penson D.F. On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol 177 (2007) 1992
5. Stier D.M., Greenfield S., Lubeck D.P., Dukes K.A., Flanders S.C., Henning J.M., et al. Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer. Urology 54 (1999) 424
6. Latini D.M., Chan J.M., Cowan J.E., Arredondo S.A., Kane C.J., Penson D.F., et al. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology 68 (2006) 1242
7. Arredondo S.A., Elkin E.P., Marr P.L., Latini D.M., DuChane J., Litwin M.S., et al. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology 67 (2006) 559
8. Litwin M.S., Gore J.L., Kwan L., Brandeis J.M., Lee S.P., Withers H.R., et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 109 (2007) 2239
9. Ware J.E.J. SF-36 Health Survey: Manual and Interpretation Guide (1993), The Health Institute, New England Medical Center, Boston
10. Litwin M.S., Hays R.D., Fink A., Ganz P.A., Leake B., and Brook R.H. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 36 (1998) 1002
11. Barry M.J., Fowler Jr. F.J., O'Leary M.P., Bruskewitz R.C., Holtgrewe H.L., Mebust W.K., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148 (1992) 1549
12. Stanford J.L., Feng Z., Hamilton A.S., Gilliland F.D., Stephenson R.A., Eley J.W., et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 283 (2000) 354
13. Talcott J.A., Manola J., Clark J.A., Kaplan I., Beard C.J., Mitchell S.P., et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 21 (2003) 3979
14. Herold D.M., Hanlon A.L., and Hanks G.E. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 43 (1999) 475
15. Yancik R., Ganz P.A., Varricchio C.G., and Conley B. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 19 (2001) 1147
16. Litwin M.S., Greenfield S., Elkin E.P., Lubeck D.P., Broering J.M., and Kaplan S.H. Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice. Cancer 109 (2007) 1777
17. Katz J.N., Chang L.C., Sangha O., Fossel A.H., and Bates D.W. Can comorbidity be measured by questionnaire rather than medical record review?. Med Care 34 (1996) 73
18. Potosky A.L., Harlan L.C., Stanford J.L., Gilliland F.D., Hamilton A.S., Albertsen P.C., et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 91 (1999) 1719
19. Litwin M.S., and McGuigan K.A. Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer. J Clin Oncol 17 (1999) 2882